| DB01268 | Sunitinib | approved, investigational | yes | inhibitor | Details |
| DB00619 | Imatinib | approved | yes | antagonist | Details |
| DB00102 | Becaplermin | approved, investigational | unknown | | Details |
| DB12742 | Amuvatinib | investigational | unknown | | Details |
| DB05146 | XL820 | investigational | unknown | | Details |
| DB06043 | Olaratumab | approved, investigational | yes | antagonist | Details |
| DB06589 | Pazopanib | approved | yes | inhibitor | Details |
| DB06595 | Midostaurin | approved, investigational | yes | antagonistinhibitor | Details |
| DB08896 | Regorafenib | approved | yes | inhibitor | Details |
| DB08901 | Ponatinib | approved, investigational | unknown | inhibitor | Details |
| DB09078 | Lenvatinib | approved, investigational | yes | inhibitor | Details |
| DB09079 | Nintedanib | approved | yes | inhibitor | Details |
| DB10772 | Foreskin keratinocyte (neonatal) | approved | yes | agonist | Details |
| DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
| DB12147 | Erdafitinib | approved, investigational | unknown | substrate | Details |
| DB14840 | Ripretinib | approved | yes | inhibitor | Details |
| DB14840 | Ripretinib | approved | unknown | inhibitor | Details |
| DB11800 | Tivozanib | approved, investigational | unknown | inhibitor | Details |